share_log

Olema Pharmaceuticals Q4 EPS $(0.49) Misses $(0.48) Estimate

Olema Pharmaceuticals Q4 EPS $(0.49) Misses $(0.48) Estimate

Olema Pharmaceuticals第四季度每股收益美元(0.49美元)未达到预期(0.48美元)
Moomoo 24/7 ·  03/11 16:04

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.48) by 2.08 percent. This is a 24.62 percent increase over losses of $(0.65) per share from the same period last year.

奥莱玛制药(纳斯达克股票代码:OLMA)公布的季度亏损为每股0.49美元,比分析师普遍预期的0.48美元(0.48美元)低2.08%。这比去年同期每股亏损0.65美元(0.65)增长了24.62%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发